Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.
Mã chứng khoánBVS
Tên công tyBioventus Inc
Ngày IPOFeb 11, 2021
Giám đốc điều hànhMr. Robert E. Claypoole
Số lượng nhân viên930
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhFeb 11
Địa chỉ4721 Emperor Boulevard, Suite 100
Thành phốDURHAM
Sàn giao dịch chứng khoánNASDAQ Global Select Consolidated
Quốc giaUnited States of America
Mã bưu điện27703
Điện thoại19194746700
Trang webhttps://www.bioventus.com/
Mã chứng khoánBVS
Ngày IPOFeb 11, 2021
Giám đốc điều hànhMr. Robert E. Claypoole
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Không có dữ liệu